Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Tables)

v3.24.2.u1
EARNINGS PER SHARE (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period:

 

    2024     2023     2024     2023  
   

For the Six Months Ended June 30,

     For the Three Months Ended June 30,  
    2024     2023     2024     2023  
Convertible notes payable     391,659       454,874       297,249       454,874  
Restricted stock units     24,848       8,589       12,424       4,295  
Warrants to purchase shares of common stock     164,740       -       164,740       -  
Total potentially dilutive shares     581,247       463,463       474,413       459,169  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share:

 

    2024     2023     2024     2023  
    Six Months Ended June 30,     Three Months Ended June 30,  
    2024     2023     2024     2023  
                         
Net loss attributable to the common stockholders   $ (1,620,471 )   $ (2,064,160 )   $ (862,383 )   $ (723,124 )
                                 
Basic weighted average outstanding shares of common stock     1,234,241       1,022,795       1,238,085       1,083,277  
Dilutive effect of options and warrants     -       -       -       -  
Diluted weighted average common stock and common stock equivalents     1,234,241       1,022,795       1,238,085       1,083,277  
                                 
Loss per share:                                
Basic and diluted   $ (1.31 )   $ (2.02 )   $ (0.70 )   $ (0.67 )